Literature DB >> 28810390

Shared decision-making - Rhetoric and reality: Women's experiences and perceptions of adjuvant treatment decision-making for breast cancer.

Neda Mahmoodi1, Sally Sargeant2.   

Abstract

This interview-based study uses phenomenology as a theoretical framework and thematic analysis to challenge existing explanatory frameworks of shared decision-making, in an exploration of women's experiences and perceptions of shared decision-making for adjuvant treatment in breast cancer. Three themes emerged are as follows: (1) women's desire to participate in shared decision-making, (2) the degree to which shared decision-making is perceived to be shared and (3) to what extent are women empowered within shared decision-making. Studying breast cancer patients' subjective experiences of adjuvant treatment decision-making provides a broader perspective on patient participatory role preferences and doctor-patient power dynamics within shared decision-making for breast cancer.

Entities:  

Keywords:  breast cancer; patient experience; phenomenology; qualitative methods; shared decision-making

Mesh:

Year:  2017        PMID: 28810390     DOI: 10.1177/1359105316689141

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  3 in total

1.  Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer.

Authors:  Rachel C Shelton; Laura E Brotzman; Danielle M Crookes; Patrick Robles; AIfred I Neugut
Journal:  Patient Educ Couns       Date:  2018-09-17

Review 2.  Shared decision making in high-grade glioma patients-a systematic review.

Authors:  Helle Sorensen von Essen; Karin Piil; Karina Dahl Steffensen; Frantz Rom Poulsen
Journal:  Neurooncol Pract       Date:  2020-07-24

3.  Patient perspectives on treatment decision-making under clinical uncertainty: chemotherapy treatment decisions among stage II colon cancer patients.

Authors:  Laura E Brotzman; Danielle M Crookes; Jessica D Austin; Alfred I Neugut; Rachel C Shelton
Journal:  Transl Behav Med       Date:  2021-10-23       Impact factor: 3.626

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.